购物车
- 全部删除
- 您的购物车当前为空
NLRP3-IN-37 (Compound 23) 是一种NLRP3抑制剂 (EC50: 5 nM),可用于研究NLRP3相关疾病,如痛风、假痛风、CAPS、NASH纤维化、心力衰竭、特发性心包炎、特应性皮炎、炎症性肠病、阿尔茨海默病、帕金森病和创伤性脑损伤。
NLRP3-IN-37 (Compound 23) 是一种NLRP3抑制剂 (EC50: 5 nM),可用于研究NLRP3相关疾病,如痛风、假痛风、CAPS、NASH纤维化、心力衰竭、特发性心包炎、特应性皮炎、炎症性肠病、阿尔茨海默病、帕金森病和创伤性脑损伤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | NLRP3-IN-37 (Compound 23), an NLRP3 inhibitor (EC50: 5 nM), can be used for research on NLRP3-related conditions, including gout, pseudogout, CAPS, NASH fibrosis, heart failure, idiopathic pericarditis, atopic dermatitis, inflammatory bowel disease, Alzheimer's Disease, Parkinson's Disease, and traumatic brain injury [1]. |
分子量 | 429.44 |
分子式 | C22H22F3N5O |
CAS No. | 3033054-51-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容